secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001213900-25-045109
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical CFO David R. Wells departs; CEO Lucas becomes interim CFO
-----------------------------------------------------------------------

- David R. Wells ceased as CFO effective May 16, 2025, without cause.
- Wells entitled to separation benefits per his August 2023 employment agreement.
- CEO Brent T. Lucas will serve as interim principal financial officer.
- Search for a permanent successor CFO has been initiated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/0001213900-25-045109-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025045109/ea0242673-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-045109

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer